The prionoses and other conformational disorders

Amyloid

Volumn 5, Issue 3, 1998, Pages 212-224

  Wisniewski, Thomas ^a   Aucouturier, Pierre ^a   Soto, Claudio ^a   Frangione, Blas ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Alzheimer's disease; Amyloid; Conformational diseases; Prion

Indexed keywords

AMYLOID BETA PROTEIN;

ALZHEIMER DISEASE; ANIMAL; CHEMISTRY; HUMAN; PRION; PRION DISEASE; PROTEIN CONFORMATION; REVIEW;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; HUMANS; PRION DISEASES; PRIONS; PROTEIN CONFORMATION;

EID: 0032152042     PISSN: 13506129     EISSN: None     Source Type: Journal    
DOI: 10.3109/13506129809003848     Document Type: Review

References (107)

1. Wisniewski T, Ghiso J and Frangione B (1997). Biology of Aβ amyloid in Alzheimer's disease. Neurobiol Dis 4, 313-328
2. Welch WJ and Gambetti P (1998). Chaperoning brain diseases. Nature 392, 23-24
3. Carrell RW and Lomas DA (1997). Conformational disease. Lancet 350, 134-138
4. Prusiner SB, Scott MR, DeArmond SJ and Cohen FE (1998). Prion protein biology. Cell 93, 337-348
5. Horwich AL and Weismann JS (1997). Deadly conformations-protein misfolding in prion diseases. Cell 89, 499-510
6. Wisniewski T and Frangione B (1996). Molecular biology of brain aging and neurodegenerative disorders. Acta Neurobiol Exp 56, 267-279
7. Gordon WS (1946). Advances in veterinary research. Vet Rec 58, 518-525
8. Gajdusek DC and Zigas V (1957). Degenerative disease of the central nervous system in New Guinea: the epidemic occurrence of "kuru" in the native population. N Eng J Med 257, 974-978
9. Gajdusek DC and Zigas V (1959). Clinical, pathological and epidemiological study of an acute progressive degenerative disease of the central nervous system among natives of the eastern highlands of New Guinea. Am J Med 26, 442-469
10. Hadlow WJ (1959). Scrapie and kuru. Lancet 11, 289-290
11. Gajdusek DC, Gibbs CJ, Jr. and Alpers M (1966).Experimental transmission of a kuru-like syndrome to chimpanzees. Nature 209, 794-796
12. Gerstmann J, Straussler E and Scheinker I (1936). Uber eine eigenartige hereditar-familiare erkrankung des Zentralnervensystems sugleich ein beitrag zur frage des vorzeitigen lokalen alterns. Z Neurol 154, 736-762
13. Ghetti B, Tagliavini F, Giaccone G, Bugiani O, Frangione B, Farlow MR and Dlouhy SR (1994). Familial Gerstmann-Straussler-Scheinker disease with neurofibrillary tangles. Mol Neurobiol 8, 41-48
14. Ghetti B, Piccardo P, Spillantini MG, Ichimiya Y, Porro M, Perini F, Kitamoto T, Tateishi J, Seiler C, Frangione B, Bugiani O, Giaccone G, Prelli F, Goedert M, Dlouhy SR and Tagliavini F (1996). Vascular variant of prion protein cerebral amyloidosis with τ-positive neurofibrillary tangles: The phenotype of the stop codon 145 mutation in PRNP. Proc Natl Acad Sci USA 93, 744-748
15. Jakob A (1921). Uber eigenartige erkrankungen des zentralnervensystems mit bemerkenswertem anatomischen befunde (spastische pseudosklerose-encephalomyelopathie mit disseminierten degenerationsherden). Z Gesamte Neurol Psychiatre 64, 147-228
16. Medori R, Trischler HJ, LeBlanc A, Villare F, Manetto V, Chen HY, Xue R, Leal S, Montagna P, Cortelli P, Tinuper P, Avoni P, Mochi M, Baruzzi A, Hauw JJ, Ott J, Lugaresi E, Autilio-Gambetti L and Gambetti P (1992). Fatal familial insomnia, a prion disease with a mutation at codon 178 of the prion protein gene. N Eng J Med 326, 444-449
17. Goldfarb LG, Petersen MB, Tabaton M, Brown P, LeBlanc AC, Montagna P, Cortelli P, Julien J, Vital C, Pendelbury WW, Haltia M, Wills PR, Hauw JJ, McKeever PE, Monari L, Schrank B, Swergold GD, Autilio-Gambetti L, Gajdusek DC, Lugaresi E and Gambetti P (1992). Fatal familial insomnia and familial Creutzfeldt-Jacob disease: disease phenotype determined by a DNA polymorphism. Science 258, 806-808
18. Collinge J (1997).Human prion diseases and bovine spongiform encephalopathy (BSE). Hum Mol Genet 6, 1699-1705
19. Collinge J, Sidle KCL, Meads J, Ironside J and Hill AF (1996). Molecular analysis of prion strain variation and the aetiology of new variant' CJD. Nature 383, 685-690
20. Bateman D, Hilton D, Love S, Zeidler M, Beck J and Collinge J (1995). Sporadic Creutzfeldt-Jakob disease in a 18-year old in the UK. Lancet 346, 1155-1156
21. Britton TC, Al-Sarraj S, Shaw C, Campbell T and Collinge J (1995). Sporadic Creutzfeldt-Jakob disease in a 16-year old in the UK. Lancet 346, 1155
22. Collee JG and Bradley R (1997). BSE: a decade on. Lancet 349, 636-641
23. Will RG, Ironside J, Zeidler M, Cousens SN, Estibeiro K, Alperovitch A, Poser S, Pocchiari M, Hofman A and Smith PG (1997). A new variant of Creutzfeldt-Jacob disease in the UK. Lancet 347, 921-925
24. Griffith JS (1967). Self-replication and scrapie. Nature 215, 1043-1044
25. Prusiner SB (1982). Novel proteinaceous infectious particles cause scrapie. Science 216, 136-144
26. Weissmann C (1996). Molecular biology of transmissible spongiform encephalopathies. FEBS Lett 389, 3-11
27. Alper T, Cramp WA, Haig DA and Clarke MC (1967). Does the agent of scrapie replicate without nucleic acid? Nature 214, 764-766
28. Latarjet R, Muel B, Haig DA, Clarke MC and Alper T (1970). Inactivation of the scrapie agent by near monchromatic ul-traviolet light. Nature 227, 1341-1443
29. Merz PA, Somerville R, Wisniewski HM and Iqbal K (1981). Abnormal fibrils from scrapie-infected brain. Acta Neuropathol 54, 63-74
30. Pan KM, Baldwin M, Njuyen J, Gassett M, Serban A, Groth D, Mehlhorn I and Prusiner SB (1993). Conversion of alpha-helices into β-sheets features in the formation of scrapie prion poteins. Proc Natl Acad Sci (USA) 90, 10962-10966
31. Caughey B, Raymond GJ, Kocisko DA and Lansbury PT, Jr. (1997). Scrapie infectivity correlates with converting activity, protease resistance, and aggregation of scrapie-associated prion protein in guanidine denaturation studies. J Virol 71, 4107-4110
32. Safar J, Roller PP, Gajdusek DC and Gibbs CJ, Jr. (1993). Thermal stability and conformational transitions of scrapie amyloid (prion) protein correlates with infectivity. Protein Sci 2, 2206-2216
33. Collinge J, Sidle KCL, Meads J, Ironside J and Hill AF (1996). Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD. Nature 383, 685-690
34. Liao YCJ, Lebo RV, Clawson GA and Smuckler EA (1986). Human prion protein cDNA: molecular cloning, chromosomal mapping and biological implications. Science 233, 364-367
35. Oesch B, Westaway D, Walchli M, McKinley MP, Kent SBH, Aebersold R, Barry RA, Tempst P, Teplow DB, Hood L, Prusiner SB and Weissman C (1985). A cellular gene encodes scrapie PrP 27-30 protein. Cell 40, 735-746
36. Kretzschmar H, Prusiner SB, Stowring LE and DeArmond SJ (1986). Scrapie prion protein are synthesized in neurons. Am J Pathol 122, 1-5
37. Chesebro B, Race R, Wehrly K, Nishio J, Bloom M, Lechner D, Bergstrom S, Robbins K, Mayer L and Keith JM (1985). Identification of scrapie prion protein-specific mRNA in scrapie infected and uninfected brain. Nature 315, 331-333
38. Taraboulos A, Raeber A, Borchelt DR, Serban D and Prusiner SB (1992). Synthesis and trafficking of prion proteins in cultured cells. Mol Biol Cell 3, 851-863
39. Shyng SL, Huber MT and Harris DA (1993). A prion protein cycles between the cell surface and endocytic compartment in cultured neuroblastoma cells. J Biol Chem 268, 15922-15928
40. Harris DA, Huber MT, Vankijken P, Shyng SL, Chait BT and Wang R (1993). Processing of a cellular prion protein: identification of N-terminal and C-terminal cleavage sites. Biochem 32, 1009-1016
41. Kitamoto T, Iizuka T and Tateishi J (1993). An amber mutation of prion protein in Gerstmann-Straussler syndrome with mutant PrP plaques. Biochem Biophys Res Commun 192, 525-531
42. Dlouhy S, Hsiao K, Farlow M, Foroud T, Conneally PM, Johnson P, Prusiner SB, Hodes ME and Ghetti B (1992). Linkage of the Indiana kindred of Gertmann-Straussler Scheinker disease to the prion protein gene. Nat Genet 1, 64-67
43. Hsiao KK, Dlouhy S, Farlow M, Cass C, DaCosta M, Conneally PM, Hodes ME, Ghetti B and Prusiner SB (1992). Mutant prion proteins in Gerstmanri-Straussler-Scheinker disease with neurofibrillary tangles. Nature Genet 1, 68-71
44. Bueler H, Fischer M, Lang Y, Bluethmann H, Lipp HP, DeArmond SJ, Prusiner SB, Aguet M and Weismann JS (1992). Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein. Nature 356, 577-582
45. Manson JC, Clarke AR, Hooper ML, Aitchison L, McConnell I and Hope J (1994). 129/Ola mice carrying a null mutation in PrP that abolishes mRNA production are developmentally normal. Mol Neurobiol 8, 121-127
46. Tobler I, Gaus SE, Deboer T, Achermann P, Fischer M, Rülicke T, Moser M, Oesch B, McBride PA and Manson JC (1996). Altered circadian activity rhythms and sleep in mice devoid of prion protein. Nature 380, 639-642
47. Collinge J, Whittington MA, Sidle KC, Smith CJ, Palmer MS, Clarke AR and Jefferys JGR (1994). Prion protein is necessary for normal synaptic function. Nature 370, 295-297
48. Liedo PM, Tremblay P, DeArmond SJ, Prusiner SB and Nicoll RA (1996). Mice deficient for prion protein exhibit normal neuronal excitability and synaptic transmission in the hippocampus. Proc Natl Acad Sci (USA) 93, 2403-2407
49. Sakaguchi S, Katamine S, Nishida N, Moriuchi R, Shigematsu K, Sugimoto T, Nakatani A, Kataoka Y, Houtani T and Shirabe S (1996). Loss of cerebellar Purkinje cells in aged mice homozygous for a disrupted PrP gene. Nature 380, 528-531
50. Bueler H, Aguzzi A, Sailer A, Greiner RA, Autenried P, Aguet M and Weissmann C (1993). Mice devoid of PrP are resistant to scrapie. Cell 73, 1339-1347
51. Prusiner SB, Groth D, Serban A, Koehler R, Foster D, Torchia M, Burton D, Yang SL and DeArmond SJ (1993). Ablation of the prion protein (PrP) gene in mice prevents scrapie and facilitates production of anti-PrP antibodies. Proc Natl Acad Sci (USA) 90, 10608-10612
52. Telling GC, Haga T, Torchia M, Tremblay P, DeArmond SJ and Prusiner SB (1996). Interactions between wild-type and mutant prion proteins modulate neurodegeneration transgenic mice. Genes Dev 10, 1736-1750
53. Hsiao K, Groth D, Scott M, Yang SL, Serban H, Rapp D, Foster D, Torchia M, DeArmond SJ and Prusiner SB (1994). Serial transmission in rodents of neurodegeneration from transgenic mice expressing mutant prion protein. Proc Natl Acad Sci (USA) 91, 9126-9130
54. Liberski PP (1995). Prions, β-sheets and transmissible dementias: is there still something missing? Acta Neuropathol 90, 113-125
55. Bessen RA and Marsh RF (1992).Biochemical and physical properties of the prion protein from two strains of the transmissible mink encephalopathy agent. J Virol 66, 2096-2101
56. Bessen RA and Marsh RF (1994). Distinct PrP properties suggest the molecular basis of strain variation in transmissible mink encephalopathy. J Virol 68, 7859-7868
57. Parchi P, Castellani R, Capellari S, Ghetti B, Young K, Chen SG, Farlow M, Dickson DW, Sima AAF, Trojanowski JQ, Petersen RB and Gambetti P (1996). Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jacob disease. Ann Neurol 39, 767-778
58. Parchi P, Capellari S, Chen SG, Petersen RB, Gambetti P, Kopp N, Brown P, Kitamoto T, Tateishi J, Giese A and Kretzschmar H (1997). Typing prion isoforms. Nature 386, 232-233
59. Lasmézas CI, Deslys JP, Demaimay R, Adjou KT, Lamoury F, Dormont D, Robain O, Omside J and Hauw JJ (1996). BSE transmission to macaques. Nature 381, 743-744
60. Wisniewski T and Frangione B (1992). Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid. Neurosci Lett 135, 235-238
61. Wisniewski T, Lalowski M, Golabek AA, Vogel T and Frangione B (1995). Is Alzheimer's disease an apolipoprotein E amyloidosis? Lancet 345, 956-958
62. Soto C, Golabek AA, Wisniewski T and Castaño EM (1996). Alzheimer's soluble β-amyloid is conformationally modified by apolipoproteins in vitro. Neuroreport 7, 721-725
63. Wisniewski T, Golabek AA, Matsubara E, Ghiso J and Frangione B (1993). Apolipoprotein E: binding to soluble Alzheimer's beta-amyloid. Biochem Biophys Res Commun 192, 359-365
64. Wisniewski T, Castano EM, Golabek AA, Vogel T and Frangione B (1994). Acceleration of Alzheimer's fibril formation by apolipoprotein E in vitro. Am J Pathol 145, 1030-1035
65. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL and Pericak-Vance MA (1993). Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261, 921-923
66. Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance M, Enghild J, Salvesen GS and Roses AD (1993). Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci (USA) 90, 1977-1981
67. Bales KR, Verina T, Dodel RC, Du YS, Altstiel L, Bender M, Hyslop P, Johnstone EM, Little SP, Cummins DJ, Piccardo P, Ghetti B and Paul SM (1997). Lack of apolipoprotein E dramatically reduces amyloid β-peptide deposition. Nature Gen 17, 263-264
68. Tatzeit J, Maeda N, Pekny M, Yang SL, Betsholtz C, Eliasson C, Cayetano J, Camerino AP, DeArmond SJ and Prusiner SB (1996). Scrapie in mice deficient in apolipoprotein E or glial fibrillary acidic protein. Neurol 47, 449-453
69. Telling GC, Scott M, Hsiao KK, Foster D, Yang SC, Torchia M, Sidla KCL, Collinge J, DeArmond SJ and Prusiner SB (1994). Transmission to Creutzfeldt-Jacob disease from human to transgenic mice expressing chimeric human-mouse prion protein. Proc Natl Acad Sci (USA) 91, 9936-9940
70. Telling GC, Scott M, Mastrianni J, Gabizon R, Torchia M, Cohen FE, DeArmond SJ and Prusiner SB (1995). Prion propagation in mice expressing human and chimeric PrP transgenes implicates the interaction of cellular PrP with another protein. Cell 83, 79-90
71. Caughey B and Race RE (1992). Potent inhibition of scrapie associated PrP accumulation by Congo Red. J Neurochem 59, 768-771
72. Tagliavini F, McArthur RA, Canciani B, Giaccone G, Porro M, Bugiani M, Lievens PM, Bugiani O, Peri E, Dall'Ara P, Rocchi M, Poli G, Forloni G, Bandiera T, Varasi M, Suarato A, Cassutti P, Cervini MA, Lansen J, Salmona M and Post C (1997). Effectiveness of anthracycline against experimental prion disease in Syrian hamsters. Science 276, 1119-1122
73. Kim CA and Berg JM (1993). Thermodynamic beta-sheet properties measured using a zinc-finger host peptide. Nature 362, 267-270
74. Wouters MA and Curmi PMG (1994). An analysis of side chain interactions and pair correlations within antiparallel beta-sheets: the differences between backbone hydrogen-bonded and non-hydrogen bonded residue pairs. Protein Sci 2, 43
75. Wetzel R (1994). Mutations and off-pathway aggregation of proteins. Trends Biotechnol 12, 193-198
76. Soto C, Kindy MS, Baumann M and Frangione B (1996).Inhibition of Alzheimer's amyloidosis by peptides that prevent β-sheet conformation. Biochem Biophys Res Commun 226, 672-680
77. Soto C, Sigurdsson EM, Morelli L, Kumar A, Castaño EM and Frangione B (1998). β-sheet breaker peptides inhibit fibrillogenesis in a rat brain model of amyloidosis: potential Alzheimer's therapy. Nat Med 4, 822-826
78. Bukau B and Horwich AL (1998). The Hsp70 and Hsp60 chaperone machine. Cell 92, 351-366
79. Anfinsen CB (1973). Principles that govern the folding of protein chains. Science 181, 223-230
80. Lindquist S (1997). Mad cows meet Psi-chotic yeast: the expansion of the prion hypothesis. Cell 89, 495-498
81. Coustou V, Deleu C, Saupe S and Begueret J (1997). The protein product of the het-s heterokaryon incompatibility gene of the fungus Podospora anserina behaves as a prion analog. Proc Natl Acad Sci (USA) 94, 9773-9778
82. Levy E, Carman MD, Fernandez-Madrid I, Lieberburg I, Power MD, vanDuinen SG, Bots GTAM, Luyendijk W and Frangione B (1990). Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type. Science 248, 1124-1126
83. Wisniewski T, Ghiso J and Frangione B (1991). Peptides homologous to the amyloid protein of Alzheimer's disease containing a glutamine for glutamic acid substitution have accelerated amyloid fibril formation. Biochem Biophys Res Commun 179, 1247-1254
84. 21 to Gly on the aggregation of a synthetic fragment of the Alzheimer's amyloid β/A4 peptide. Neurosci Lett 161, 17-20
85. Castaño EM, Prelli F, Wisniewski T, Golabek AA, Kumar RA, Soto C and Frangione B (1995). Fibrillogenesis in Alzheimer's disease of amyloid beta peptides and apolipoprotein E. Biochem J 306, 599-604
86. Prelli F, Levy E, Van Duinen SG, Bots GT, Luyendijk W and Frangione B (1990). Expression of anormal and variant Alzheimer's beta-protein in amyloid of hereditary cerebral hemorrhage, Dutch type: DNA and protein diagnostic assays. Biochem Biophys Res Commun 170, 301-307
87. Collinge J, Palmer MS and Dryden AJ (1991). Genetic predisposition to iatrogenic Creutzfeldt-Jacob disease. Lancet 337, 1441-1442
88. Miyazono M, Kitamoto T, Doh-ura K, Iwaki T and Tateishi J (1992). Creutzfeldt-Jacob disease with codon 129 polymorphism (valine): a compartive study of patients with codon 129 point mutation or without mutations. Acta Neuropathol 84, 349-354
89. Riek R, Hornemann S, Wider G, Billeter M, Glockshuber R and Wüthrich K (1996). NMR structure of the mouse prion protein domain PrP(121-231). Nature 382, 180-182
90. Billeter M, Riek R, Wider G, Homemann S, Glockshuber R and Wüthrich K (1997). Prion protein NMR structure and species barrier for prion diseases. Proc Natl Acad Sci USA 94, 7281-7285
91. Riek R, Hornemann S, Wider G, Glockshuber R and Wüthrich K (1997). NMR characterization of the full-length recombinant murine prion protein, mPrP(23-231). FEBS Lett 413, 282-288
92. Goldfarb L, Brown P, McCombie WR, Goldgaber D, Swergold GD, Wills PR, Cervenakova L, Baron H, Gibbs CJ, Jr. and Gajdusek DC (1991). Transmissible familial Creutzfeldt-Jacob disease associated with five, seven, and eight extra octapeptide coding repeats in the PRNP gene. Proc Natl Acad Sci (USA) 88, 10926-10930
93. Owen F, Poulter M, Lofthouse R, Collinge J, Crow TJ, Risby D, Baker HF, Ridley RM, Hsiao K and Prusiner SB (1989). Insertion in prion protein gene in familial Creutzfeldt-Jacob disease. Lancet 1, 51-52
94. Owen F, Poulter M, Shah T, Collinge J, Lofthouse R, Baker HF, Ridley RM, McVey J and Crow TJ (1990). An in-frame insertion in the prion protein gene in familial Creutzfeldt-Jacob disease. Mol Brain Res 7, 273-276
95. Hsiao K, Baker HF, Crow TJ, Poulter M, Owen F, Terwilliger JD, Westaway D, Ott J and Prusiner SB (1989). Linkage of a prion protein missense variant to Gerstmann-Straussler syndrome. Nature 338, 342-345
96. Goldfarb LG, Brown P, Goldgaber D, Asher DM, Rubenstein R, Brown WT, Piccardo P, Kascsak RJ, Boellaard JW and Gajdusek DC (1990). Creutzfeldt-Jakob disease and kuru patients lack a mutation consistently found in the Gerstmann-Straussler-Scheinker syndrome. Exp Neurol 108, 247-250
97. Goldgaber D, Goldfarb LG, Brown P, Asher DM, Brown WT, Lin S, Teener, JW, Feinstone SM, Rubenstein R, Kascsak RJ and et al (1989). Mutations in familial Creutzfeldt-Jakob disease and Gerstmann-Straussler-Scheinker's syndrome. Exp Neurol 106, 204-206
98. Kitamoto T, Ohta M, Doh-ura K, Hitoshi S, Terao Y and Tateishi J (1993). Novel missense variants of prion protein in Creutzfeldt-Jacob disease or Gerstmann-Straussler syndrome. Biochem Biophys Res Commun 191, 709-714
99. Hsiao K, Doh-ura K, Kitamoto T, Tateishi J and Prusiner SB (1989). A prion protein amino acid substitution in ataxic Gerstmann-Straussler syndrome. Ann Neurol 26, 137
100. Nochlin D, Sumi M, Bird T, Snow AD, Leventhal CM, Beyreuther K and Masters CL (1989). Familial dementia with PrP-positive amyloid plaques: a variant of Gerstmann-Straussler syndrome. Neurol 39, 910-918
101. Goldfarb L, Brown P, Haltia M, Cathala F, McCombie WR, Kovanen J, Cervenakova L, Goldin L, Nieto A, Codec MS, Asher DM and Gajdusek DC (1992). Creutzfeldt-Jacob disease cosegregates with the codon 178Asn PRNP mutation in families of European origin. Ann Neurol 31, 274-281
102. Gabizon R, Meiner Z, Cass C, Kahana I, Avrahami D, Abramsky O, Scarlato G, Prusiner SB and Hsiao K (1991). Prion protein gene mutation in Libyan Jews with Creutzfeldt-Jabob disease. Neurol 41, 160
103. Goldfarb L, Haltia M, Brown P, Nieto A, Kovanen J, McCombie WR, Trapp S and Gajdusek DC (1991). New mutation in scrapie amyloid precursor gene (at codon 178) in Finnish Creutzfeldt-Jacob kindred. Lancet 337, 425
104. Goldfarb L, Mitrova E, Brown P, Toh BH and Gajdusek DC (1990). Mutation in codon 200 of scrapie amyloid gene in two clusters of Creuzfeldt-Jacob disease in Slovakia. Lancet 336, 514-515
105. Hsiao K, Meiner Z, Kahana E, Cass C, Kahana I, Avrahami D, Scarlato G, Abramsky O, Prusiner SB and Gabizon R (1991). Mutation of the prion protein in Libyan Jews with Creutzfeldt-Jacob disease. N Eng J Med 324, 1091-1097
106. Ripoll L, Laplanche JL, Salzmann M, Jouvet A, Planques B, Dussaucy M, Chatelain J, Beaudry P and Launay JM (1993). A new point mutation in the prion protein gene at codon 210 in Creutzfeldt-Jacob disease. Neurol 43, 1934-1938
107. Kascsak RJ, Rubenstein R, Merz PA, Tonna-DeMasi M, Fersko R, Carp RI, Wisniewski HM and Diringer H (1987). Mouse polyclonal and monoclonal antibody to scrapie-associated fibril proteins. J Virol 61, 3688-3693